Why the study?
Atrial fibrillation is rare in patients under 45 years old, and the role of cardiac sarcoidosis as a subclinical contributor to atrial fibrillation is not well understood.
Case Report (n=1)
Answers are grounded in this paper and cite their sources.
Cardiac sarcoidosis should be considered as a potential subclinical contributor in young patients presenting with refractory atrial fibrillation.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
A 2020 study conducted a case report in Atrial Fibrillation and Cardiac Sarcoidosis (n=1). Cardiac sarcoidosis was evaluated.
Synapse has enriched 10 related papers. Consider them for comparative context: